Medpace Holdings Stock News

Medpace Holdings, Inc. (NASDAQ:MEDP) CEO August J. Troendle sold 22,734 shares of Medpace stock in a transaction that occurred on Monday, December 20th. The shares were sold at an average price of $212.57, for a total transaction of $4,832,566.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is []

These smaller healthcare companies all have 10x potential for investors.

State of Michigan Retirement System grew its stake in shares of Medpace Holdings, Inc. (NASDAQ:MEDP) by 2.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,200 shares of the companys stock after acquiring an additional 200 shares during []

Related Stocks: MEDP ,

Meritage Portfolio Management increased its stake in Medpace Holdings, Inc. (NASDAQ:MEDP) by 0.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 71,997 shares of the company’s stock after buying an additional 442 shares during the quarter. Medpace comprises approximately […]

Wall Street analysts forecast that Medpace Holdings, Inc. (NASDAQ:MEDP) will post earnings of $1.25 per share for the current quarter, Zacks reports. Three analysts have provided estimates for Medpaces earnings. The highest EPS estimate is $1.27 and the lowest is $1.22. Medpace reported earnings of $1.39 per share during the same quarter last year, which []

YorkBridge Wealth Partners LLC purchased a new stake in Medpace Holdings, Inc. (NASDAQ:MEDP) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 1,156 shares of the companys stock, valued at approximately $219,000. Other institutional investors and hedge funds have also recently added to or []

Related Stocks: MEDP ,

Medpace Holdings, Inc. (NASDAQ:MEDP) major shareholder Medpace Investors, Llc sold 400 shares of Medpace stock in a transaction that occurred on Friday, December 3rd. The shares were sold at an average price of $211.48, for a total value of $84,592.00. The sale was disclosed in a legal filing with the SEC, which is available at []

Bioanalytical Testing Services Market The bioanalytical testing services market was valued at USD 1,177.67 million in 2019 and is expected to grow with a CAGR of 13.4% during the forecast period. The ''Straits Research'' report focuses on target groups of customers to help players effectively market

Medpace Holdings (MEDP) has been struggling lately, but the selling pressure may be coming to an end soon.

Related Stocks: MEDP ,

A clinical trial is a research investigation in which individuals can participate. The intent of a clinical trial is to investigate the efficacy of a treatment, medication, experimental drug or instrument. Clinical trials in the field of neurology constitute neurology

Exchange Traded Concepts LLC reduced its holdings in Medpace Holdings, Inc. (NASDAQ:MEDP) by 3.6% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 14,717 shares of the companys stock after selling 549 shares during the period. Exchange Traded Concepts LLCs holdings in Medpace were []